Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Pharmac Initiated, Clinician","Tyrosine kinase inhibitors (eg. sunitinib, pazopanib)","Renal cell carcinoma (RCC), advanced or metastatic with a good prognosis","Tyrosine kinase inhibitors (eg. sunitinib, pazopanib)",,Community and Hospital,Oncology Agents and Immunosuppressants
